Food producer Kirin and Meiji University have developed a pair of chopsticks that stimulate the taste of salt in foods with low salt content through extensive research.
This technology, which has yet to be named, accomplishes this by merely injecting a weak electric current into your food.
The difficulty was to find just the correct electrical waveform to impact the ions that are responsible for salty tastes, such as sodium chloride, such that the saltiness they create is increased.
Additionally, the ions in monosodium glutamate, which is responsible for the umami flavor of meals like miso soup, are affected by this current.
To establish a benchmark, the researchers fed patients a gel with a specific salt concentration and asked them to rate how salty it tasted.
They next gave them a gel with 30 percent less salt. Interestingly, the test respondents' ratings also revealed a surprisingly accurate decline in perceived saltiness of roughly 30%.
Tests with a low-salt miso soup yielded encouraging results, with observations that not only saltiness but also umami and overall flavor, were improved.


Merck's $6 Billion Bid for Terns Pharma Signals Bold Oncology Push
Bank of Japan Faces Rate Uncertainty Amid Middle East Oil Shock
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war?
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
SpaceX IPO Filing Expected This Week as Valuation Could Surpass $75 Billion
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Gold Prices Rise Amid Geopolitical Tensions and Safe Haven Demand
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
The four types of dementia most people don’t know exist
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Innate Pharma Reports 55% Revenue Drop and €49.2M Net Loss for 2025
How the war in Iran is already affecting UK farmers and food production
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Asian Stocks Rebound as Trump Delays Iran Strike Deadline 



